Skip to main content

PMV Pharmaceuticals, Inc.

PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001699382

No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding PMV Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of PMVP: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders9899+1
Shares46.5M42.7M−3.72M (−8.0%)
Value$144.0M$72.7M−$71.3M (−49.5%)

New holders (16)

Institutions that held PMV Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to PMVP in Q1 2024
InstitutionSharesValue% of portfolio
BML Capital Management, LLC1,306,490$2.22M1.49%
Millennium Management LLC655,461$1.11M0.00%
Opaleye Management Inc.471,481$802.1K0.17%
Acuitas Investments, LLC351,875$598.2K0.30%
Shay Capital LLC197,178$335.2K0.10%
Marshall Wace, LLP131,845$224.1K0.00%
Man Group plc114,432$194.5K0.00%
Marquette Asset Management, LLC64,009$108.8K0.02%
Mirae Asset Global Investments Co., Ltd.15,492$75.3K0.00%
Gsa Capital Partners LLP39,637$67.0K0.01%
Panagora Asset Management Inc18,705$31.8K0.00%
Belvedere Trading LLC11,419$19.4K0.00%
ADAR1 Capital Management, LLC10,000$17.0K0.00%
Avion Wealth299$1.00K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC8$130.00%
CWM, LLC165$00.00%

Sold out (15)

Institutions that held PMV Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.